tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cambridge Cognition to Present Interim Results Live
Company AnnouncementsCambridge Cognition to Present Interim Results Live
8h ago
Cambridge Cognition Raises £1.12 Million to Strengthen Financial Position
PremiumCompany Announcements
Cambridge Cognition Raises £1.12 Million to Strengthen Financial Position
4d ago
Cambridge Cognition Announces Strategic Leadership Changes
PremiumCompany Announcements
Cambridge Cognition Announces Strategic Leadership Changes
4d ago
Cambridge Cognition Reports Strong Sales Growth and Strategic Developments in H1 2025
PremiumCompany Announcements
Cambridge Cognition Reports Strong Sales Growth and Strategic Developments in H1 2025
4d ago
Cambridge Cognition Reports Strong Growth and Operational Advancements in H1 2025
PremiumCompany Announcements
Cambridge Cognition Reports Strong Growth and Operational Advancements in H1 2025
4d ago
Cambridge Cognition’s Monument Therapeutics Partners with FNIH for Schizophrenia Treatment Trial
PremiumCompany AnnouncementsCambridge Cognition’s Monument Therapeutics Partners with FNIH for Schizophrenia Treatment Trial
13d ago
Cambridge Cognition Launches AI-Driven Solution to Enhance Clinical Trial Integrity
Premium
Company Announcements
Cambridge Cognition Launches AI-Driven Solution to Enhance Clinical Trial Integrity
20d ago
Cambridge Cognition Sees Strong Sales Growth Amid Revenue Challenges
Premium
Company Announcements
Cambridge Cognition Sees Strong Sales Growth Amid Revenue Challenges
1M ago
Cambridge Cognition Successfully Concludes AGM with All Resolutions Passed
PremiumCompany Announcements
Cambridge Cognition Successfully Concludes AGM with All Resolutions Passed
2M ago
Cambridge Cognition’s Investment Achieves Positive Trial Results for Schizophrenia Treatment
PremiumCompany Announcements
Cambridge Cognition’s Investment Achieves Positive Trial Results for Schizophrenia Treatment
2M ago
Cambridge Cognition Releases 2024 Annual Report and AGM Notice
PremiumCompany Announcements
Cambridge Cognition Releases 2024 Annual Report and AGM Notice
3M ago
Cambridge Cognition Announces Change in Voting Rights Structure
PremiumCompany Announcements
Cambridge Cognition Announces Change in Voting Rights Structure
4M ago
Cambridge Cognition Reports Growth and Strategic Advancements in 2024
PremiumCompany AnnouncementsCambridge Cognition Reports Growth and Strategic Advancements in 2024
4M ago
Cambridge Cognition Wins £1 Million Contract for Autoimmune Disease Trial
Premium
Company Announcements
Cambridge Cognition Wins £1 Million Contract for Autoimmune Disease Trial
5M ago
Cambridge Cognition Announces Change in Major Shareholdings
Premium
Company Announcements
Cambridge Cognition Announces Change in Major Shareholdings
5M ago
Cambridge Cognition Secures Major Contract for Phase 3 Trials in Adolescent Depression
PremiumCompany Announcements
Cambridge Cognition Secures Major Contract for Phase 3 Trials in Adolescent Depression
5M ago
Cambridge Cognition’s CANTAB Platform Validated in Major Brain Health Study
PremiumCompany Announcements
Cambridge Cognition’s CANTAB Platform Validated in Major Brain Health Study
6M ago
Cambridge Cognition Advances Schizophrenia Cognitive Assessment Tools
PremiumCompany Announcements
Cambridge Cognition Advances Schizophrenia Cognitive Assessment Tools
7M ago
Cambridge Cognition Strengthens Board with New Non-Executive Director Appointment
PremiumCompany Announcements
Cambridge Cognition Strengthens Board with New Non-Executive Director Appointment
7M ago
Cambridge Cognition Expands CNS Clinical Trial Services with New Rater Training Launch
PremiumCompany AnnouncementsCambridge Cognition Expands CNS Clinical Trial Services with New Rater Training Launch
7M ago
Cambridge Cognition Expands Partnership with Actinogen for Alzheimer’s Trial
Premium
Company Announcements
Cambridge Cognition Expands Partnership with Actinogen for Alzheimer’s Trial
8M ago
Cambridge Cognition’s CANTAB Plays Key Role in New Schizophrenia Drug Trials
Premium
Company Announcements
Cambridge Cognition’s CANTAB Plays Key Role in New Schizophrenia Drug Trials
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >